Response to oral gliclazide in a pre-pubertal child with hepatic nuclear factor-1 alpha maturity onset diabetes of the young
暂无分享,去创建一个
V. Mathew | Abdelhadi M. Habeb | Elizabeth T. George | Verghese Mathew | Andrew L. Hattersley | A. Habeb | A. Hattersley | E. T. George
[1] A. Hattersley,et al. No deterioration in glycemic control in HNF-1alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. , 2003, Diabetes care.
[2] T. Frayling,et al. Mutations in the Hepatocyte Nuclear Factor–1α Gene Are a Common Cause of Maturity-Onset Diabetes of the Young in the U.K. , 1997, Diabetes.
[3] T. Frayling,et al. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. , 2001, Diabetes.
[4] P. Heinke,et al. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[5] C. Bellanné-Chantelot,et al. The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 , 2008, Diabetes.
[6] A. Hattersley,et al. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. , 2006, Endocrinology.
[7] A. Hattersley,et al. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor‐1α gene mutations: evidence for pharmacogenetics in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.
[8] L. Groop,et al. Chronic diabetic complications in patients with MODY3 diabetes , 1998, Diabetologia.
[9] A. Hattersley,et al. Mutations in hepatocyte nuclear factor-1β and their related phenotypes , 2005, Journal of Medical Genetics.
[10] A. Hattersley,et al. Genetic cause of hyperglycaemia and response to treatment in diabetes , 2003, The Lancet.
[11] A. Hattersley,et al. ISPAD Clinical Practice Consensus Guidelines 2006–2007 The diagnosis and management of monogenic diabetes in children , 2006, Pediatric diabetes.
[12] P. Froguel,et al. HNF1α controls renal glucose reabsorption in mouse and man , 2000 .
[13] S. Rich,et al. Determinants of the development of diabetes (maturity-onset diabetes of the young-3) in carriers of HNF-1alpha mutations: evidence for parent-of-origin effect. , 2002, Diabetes care.
[14] P. Froguel,et al. HNF1alpha controls renal glucose reabsorption in mouse and man. , 2000, EMBO reports.
[15] T. Hansen,et al. The genetic abnormality in the beta cell determines the response to an oral glucose load , 2002, Diabetologia.
[16] T. Frayling,et al. Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. , 2002, Diabetes care.
[17] M. Maringa,et al. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea. , 2008, Diabetes research and clinical practice.
[18] D. Dunger,et al. First UK survey of paediatric type 2 diabetes and MODY , 2004, Archives of Disease in Childhood.
[19] P. Heinke,et al. A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor‐1α (HNF‐1α) gene , 1998 .
[20] E. P. Atance,et al. Diabetes de comienzo en la infancia tratada con sulfonilureas , 2008 .
[21] T. Frayling,et al. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. , 2001, Diabetes.